Epidemiology and outcomes of pediatric autosomal recessive polycystic kidney disease in the Middle East and North Africa
Pediatric Nephrology · 2024-09 · 39 (9) · 2569-2578
DOI: 10.1007/s00467-024-06281-0 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pediatric Nephrology, online erschienen am 23.01.2024. Verfasst von Mohamed A Salman und 2 weiteren Autor:innen. Beteiligte Einrichtung: CTI Clinical Trial and Consulting Services, Cairo, Egypt. moh.salman.md@gmail.com. Hauptthemen laut MEDLINE: Polycystic Kidney, Autosomal Recessive. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 60 Literaturangaben.
Abstract (Originalsprache)
The incidence of rare diseases is expected to be comparatively higher in the Middle East and North Africa (MENA) region than in other parts of the world, attributed to the high prevalence of consanguinity. Most MENA countries share social and economic statuses, cultural relativism, religious beliefs, and healthcare policies. Polycystic kidney diseases (PKDs) are the most common genetic causes of kidney failure, accounting for nearly 8.0% of dialysis cases. The development of PKDs is linked to variants in several genes, including PKD1, PKD2, PKHD1, DZIP1L, and CYS1. Autosomal recessive PKD (ARPKD) is the less common yet aggressive form of PKD. ARPKD has an estimated incidence between 1:10,000 and 1:40,000. Most patients with ARPKD require kidney replacement therapy earlier than patients with autosomal dominant polycystic kidney disease (ADPKD), often in their early years of life. This review gathered data from published research studies and reviews of ARPKD, highlighting the epidemiology, phenotypic presentation, investigations, genetic analysis, outcomes, and management. Although limited data are available, the published literature suggests that the incidence of ARPKD may be higher in the MENA region due to consanguineous marriages. Patients with ARPKD from the MENA region usually present at a later disease stage and have a relatively short time to progress to kidney failure. Limited data are available regarding the management practice in the region, which warrants further investigations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- CTI Clinical Trial and Consulting Services, Cairo, Egypt. moh.salman.md@gmail.com.
- Smart Health Unit, University of East London, London, E16 2, UK.
- Center of Pediatric Nephrology & Transplantation, Kasr Al Ainy Medical School, Cairo University, Cairo, Egypt.
- Egypt Center for Research and Regenerative Medicine (ECRRM), Cairo, Egypt.
- Egyptian Group for Orphan Renal Diseases (EGORD), Cairo, Egypt.
ORCID-Profile: Mohamed A Salman
Zitieren
APA
Salman, M. A., Elgebaly, A., & Soliman, N. A. (2024). Epidemiology and outcomes of pediatric autosomal recessive polycystic kidney disease in the Middle East and North Africa. Pediatric Nephrology, 39(9), 2569-2578. https://doi.org/10.1007/s00467-024-06281-0
Vancouver
Salman MA, Elgebaly A, Soliman NA. Epidemiology and outcomes of pediatric autosomal recessive polycystic kidney disease in the Middle East and North Africa. Pediatric Nephrology. 2024;39(9):2569-2578. doi:10.1007/s00467-024-06281-0
BibTeX
@article{Salman2024,
author = {Salman, Mohamed A and Elgebaly, Ahmed and Soliman, Neveen A},
title = {Epidemiology and outcomes of pediatric autosomal recessive polycystic kidney disease in the Middle East and North Africa},
journal = {Pediatric Nephrology},
year = {2024},
volume = {39},
number = {9},
pages = {2569--2578},
doi = {10.1007/s00467-024-06281-0}
}
EUVIMED